Search research articles
Contact Us
Filters
Showing results (661-670 of 717) with videos related to
Page
of 72
Sort By:
Lancet (London, England)
|
June 11, 2017
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
H Miles Prince, Youn H Kim, Steven M Horwitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma
Pallawi Torka, Tatyana Feldman, Kerry J Savage, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta-Shah, Steven M Horwitz, Stephen Ansell, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2017
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States
Eric D Hsi, Steven M Horwitz, Kenneth R Carson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 14, 2023
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study
Mark T Corkum, Mark K Buyyounouski, Albert J Chang, et al.
The Pediatric Infectious Disease Journal
|
September 14, 2022
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection
Laura D Zambrano, Kathleen N Ly, Ruth Link-Gelles, et al.
Blood Cancer Journal
|
June 14, 2018
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
Andrew M Intlekofer, Erel Joffe, Connie L Batlevi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2019
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study
Michael S Khodadoust, Alain H Rook, Pierluigi Porcu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Page
of 72
Search research articles
Search
Showing results (661-670 of 717) with videos related to
Sort By:
Page
of 72
Lancet (London, England)
|
June 11, 2017
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
H Miles Prince, Youn H Kim, Steven M Horwitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma
Pallawi Torka, Tatyana Feldman, Kerry J Savage, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta-Shah, Steven M Horwitz, Stephen Ansell, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2017
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States
Eric D Hsi, Steven M Horwitz, Kenneth R Carson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 14, 2023
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study
Mark T Corkum, Mark K Buyyounouski, Albert J Chang, et al.
The Pediatric Infectious Disease Journal
|
September 14, 2022
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection
Laura D Zambrano, Kathleen N Ly, Ruth Link-Gelles, et al.
Blood Cancer Journal
|
June 14, 2018
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
Andrew M Intlekofer, Erel Joffe, Connie L Batlevi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2019
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study
Michael S Khodadoust, Alain H Rook, Pierluigi Porcu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Page
of 72